Lung Cancer Patients Treated with IMRT Have Less Lung Toxicity and Better Tolerance to Chemotherapy

Home / Blog / Lung Cancer Patients Treated with IMRT Have Less Lung Toxicity and Better Tolerance to Chemotherapy
Lung Cancer Patients Treated with IMRT Have Less Lung Toxicity and Better Tolerance to Chemotherapy
April 26, 2020April 26, 2020
0

The analysis of an international clinical trial including patients suffering from locally advanced non-small cell lung cancer (NSCLC) showed that those treated with intensity modulated radiation therapy (IMRT) had a significant decrease in lung toxicity and improved chemotherapy tolerance when compared to patients treated with 3-dimensional conformal radiation therapy (3-D CRT). The results were presented by Stephen Chun, M.D., fellow, Radiation Oncology at The University of Texas MD Anderson Cancer Center during the American Society for Radiation Oncology’s 57th Annual Meeting. The 3-D CRT…

You must be logged in to read/download the full post.